{"result": {"id": "chatcmpl-436", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**PTX**, also known as **paclitaxel**, is a substance used in the treatment of cancer, particularly gastric cancer. It is currently under investigation as part of drug trials, with researchers studying its properties and potential applications in various research settings. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743162055, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 53, "prompt_tokens": 217, "total_tokens": 270, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"PTX\"\nDescription List: [\"**PTX**, also known as **paclitaxel**, is a substance used in the treatment of cancer, particularly gastric cancer. \\n\", \"The **PTX** chemical compound is being researched and is currently a subject of study, specifically as part of a drug trial.  It's being used in various research settings to understand its properties and potential applications. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_7291a1c3c48f9b6c224f5a22ad197c73d48186ece6c2b1b33550ccf836cd60f8_v2"}